تابينتادول: الفرق بين النسختين

| bioavailability = 31.9 ± 6.8% (oral)<ref>{{ مرجع كتاب | المؤلف = Terlinden, R.; Ossig, J.; Fliegert, F.; Gohler, K. | سنة = 2006 | chapter = Pharmacokinetics, Excretion and Metabolism of Tapentadol HCl, a Novel Centrally Acting Analgesic in Healthy Subjects | العنوان = Program and Abstracts of the 25th Annual Scientific Meeting of the American Pain Society; May 3–6, 2006 San Antonio, Texas | id = Poster 689 }}</ref>

| protein_bound = 20%<ref name = MD/>

| elimination_half-life = 4 hours<ref name = MD/>

| excretion = Urine (73%) and faeces<ref name = MD>{{cite web|title=Tapentadol|work=Martindale: The Complete Drug Reference|publisher=Pharmaceutical Press|date=14 November 2011|accessdate=2 April 2014|url=http://www.medicinescomplete.com/mc/martindale/current/ms-21327-p.htm|editor=Brayfield, A}}</ref>